AngioDynamics, Inc. (ANGO) vs Embecta Corp. (EMBC)
AngioDynamics, Inc. and Embecta Corp. are both Medical Instruments & Supplies companies. AngioDynamics, Inc. is the larger, with a market value of $631.6M against $316.2M — 2.0× the size. AngioDynamics, Inc. has negative trailing earnings, so its P/E is not meaningful; Embecta Corp. trades at 4.0×. AngioDynamics, Inc. grew revenue faster over the last twelve months: 9.46% against −7.60%. Embecta Corp. has the higher net margin (8.59% vs −11.5%) and the higher return on invested capital (21.4% vs −21.3%). Across the 18 metrics below, Embecta Corp. leads on 13 and AngioDynamics, Inc. on 5.
Valuation
Profitability
| Metric | ANGO | EMBC | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 54.62% | 59.03% | 54.62% |
| Operating margin | (12.47%) | 21.94% | 1.64% |
| Net margin | (11.48%) | 8.59% | 0.00% |
| Free cash flow margin | 0.16% | 17.15% | 1.61% |
| Return on equity | (20.77%) | (13.65%) | 0.00% |
| Return on assets | (13.43%) | 7.22% | 0.00% |
| Return on invested capital | (21.34%) | 21.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack